Dark Forest Capital Management LP Ocugen, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.45 - $0.88 $10,783 - $21,088	23,964 New	23,964 $12,000
Q1 2022 May 13, 2022	SELL	$2.34 - $4.72 $50,974 - $102,820	-21,784 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.38 - $15.67 $95,413 - $341,355	21,784 New	21,784 $99,000
Q3 2021 Nov 12, 2021	SELL	$6.36 - $8.51 $1,901 - $2,544	-299 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $1,650 - $4,688	299 New	299 $2,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.